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Secondary metabolites of marine sponge Dendrilla nigra were tested for determining the efficacy
of controlling shrimp bacterial pathogens. Based on the exploratory experiments, the chosen dose of
D. nigra (500 mg/kg of shrimp) was used for pilot experiment. The percent relative protection (PRP)
of shrimps treated with Dendrilla feed and challenged with various concentrations of bacterial
pathogen was evaluated. Dendrilla feed elicited complete protection (100% survival) against the
most common shrimp pathogens such as luminescent Vibrio harveyi and Vibrio alginolyticus.
Results of combined bacterial challenge indicated that Dendrilla was a broad spectrum vibriostatic
agent. Invariably, the survival of treated shrimp against the bacterial infection was significant at
p<0.01 level. Based on the present findings, it could be inferred that the secondary metabolites of D.
nigra form an excellent source for developing potent antibacterial agents to combat bacterial diseases
of shrimp and replace the conventional antibiotics.
D 2004 Elsevier B.V. All rights reserved.
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1. Introduction
Shrimp farming is a lucrative industry in several countries of Asia particularly Indonesia,
Taiwan, China and India. However, diseases are recognized as a major constraint as well as0044-8486/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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come in direct contact with the ambient microbes continuously, which may act as
opportunistic pathogens (Raa et al., 1992). Therefore, it is very difficult to prevent diseases
caused by opportunistic or secondary pathogens during the entire culture period. Medica-
tion of aquatic organisms cannot be restricted to the diseased individuals and as a result,
resistant microbial strains may develop, which change the normal microbial composition
leading to massive outbreaks of the disease. Initial management of such outbreaks by
reducing the stocking density or carrying capacities is considered as uneconomical due to
increased production costs. The total sterility of rearing water in the entire culture period by
pretreatment is practically impossible (Alabi et al., 1999). The pre-infection therapy such as
vaccine and immunostimulants are still under investigation for the field use. Although post-
infection therapy using medicated feeds incorporated with antibiotics is possible to a certain
extent (de la Pena et al., 1992), the impact of antibiotics in the environment and consumer
health is highly risky (Selvin and Lipton, 2003a). Therefore, cost-effective treatment
technologies need to be developed for controlling/preventing such outbreaks especially due
to opportunistic and secondary pathogenic invaders.
Sponges are filter feeders, which live in areas with strong currents or wave action. Most
carnivorous animals avoid sponges because of the splinter-like spicules and toxic
chemicals produced/sequestered by the sponge. Sponges were reported as potential source
of antibacterial secondary metabolites (Nakamura et al., 1991; Mokashe et al., 1994; Pettit
et al., 1996; Shen et al., 1998; Matsunaga et al., 2000, 2001). However, the overexploi-
tation of sponges may pose imminent threat to their natural bed (Thomas, 1998).
Therefore, in the present study, due emphasis was given for the ecofriendly utilization
of bycatch sponges as source material for the development of novel shrimp therapeutants.2. Materials and methods
Forty days old farm reared juveniles of 200 black tiger shrimp, Penaeus monodon were
collected from an extensive farm located in Kanyakumari coast (southeast coast of India).
They were conditioned in 1000 l capacity fibre reinforced plastic tanks at optimum
hydrological conditions such as salinity (35 ppt), temperature (30F2 jC), pH (7.8) and
constant aeration with 50% water exchange daily. They were fed with pellet feed at a rate
of 3.2% of total biomass in three equal installments. The feeding rate and schedule were
adjusted based on the unutilized feed remains. At the onset of experiments, shrimp density
was adjusted to 1 individual per 10 l of water in 100 l glass aquaria. Prior to the challenge
experiments, random sampling of shrimp was made for the bacterial isolation to ensure the
shrimp were pathogen free.
The sponge, Dendrilla nigra collected as bycatch in fishing nets, were used for the
isolation of secondary metabolites using methanol–dichloromethane (1:1) (Selvin and
Lipton, 2004). In brief, the sponge was cut into small pieces and homogenized in a tissue
homogenizer (Omni) using methanol as solvent. They were extracted thrice with
methanol–dichloromethane (1:1) and the combined extract was concentrated in a rotary
vacuum evaporator (Buchi) at room temperature. Commercial pelleted shrimp grower feed
No. 1 (C.P. feeds, Cochin) was used for the preparation of sprayed medicated feed. The
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Exploratory (dose selecting) experiments were conducted with broad range of the test
compounds. Chosen concentrations such as: 100, 1000 and 2000 mg/kg shrimp of D.
nigra was prepared in normal saline (NS). Ten shrimps (abw=8.5 g) per group (in
triplicates) were injected intramuscularly with 0.1 ml of appropriate dose. The immediate
reflexes and mortality were observed every hour for the first 6 h and every 24 h for 7 days.
Based on the exploratory experiments, narrow ranges were administered to the experi-
mental shrimp to determine the LD50. LD50 value of D. nigra was determined (420 mg/kg
of shrimp) by probit analysis. The dosing regimens were determined on the basis of active
ingredients (in terms of minimum inhibitory concentration=9 mg/ml) in D. nigra (Selvin
and Lipton, 2004). Based on the exploratory experiments, the chosen dose of D. nigra
(500 mg/kg of shrimp) was incorporated in the feed by spraying appropriate concentration
of extract on the surface of the feed at a rate of 3.2% of the shrimp body weight daily
(Selvin et al., 2004).
The shrimps (100 numbers) with an average body weight of 8 and 10.5 g range was
treated with medicated feed at a rate of 3.2% of the body weight for a period of 15 days. On
the 16th day, three groups each of healthy pretreated and control shrimps (10 nos/group)
were challenged with MLD and lethal dose of appropriate bacterial pathogens. For the
challenge experiment, one type culture Vibrio fischeri (ATCC 7744, American Type Culture
Collection, Manassas, VA), two shrimp isolates Vibrio harveyi (obtained from marine
biotechnology laboratory) and Vibrio alginolyticus (Selvin and Lipton, 2003) and one fish
isolate Aeromonas sp. in addition to a potentiated pathogen (V. harveyi, 5106+V.
alginolyticus, 5106=107 cfu/shrimp) were used. An 18 h shake culture of appropriate
pathogens was centrifuged at 4800g for 15 min for the preparation of inoculum. Cell
pellets were washed twice with NS, resuspended and serially diluted in NS and enumerated
using a Petroff–Hausser chamber and by plating on nutrient agar (supplemented with 2%
NaCl) plates to obtain counts of colony forming units (cfu). The appropriate MLD and lethal
dose of the isolates were injected intramuscularly at the ventral side between the second and
third segment in 0.1 ml NS using a 1 ml tuberculin syringe. They were observed for a period
of 15 days for mortality and infections. The infected and moribund shrimps were examined
for external signs of infection using standard methods (Austin and Austin, 1989). The
mortality/infectivity percentages were estimated after Sung et al. (1994).
%Mortality ¼ No: of dead=infected shrimp A
Total no: of dead A
 
 100
where, A is the number of dead shrimp in 1 day after infection, which is considered to die due
to administration stress. Based on the mortality rate, the percent relative protection (PRP) of
challenged shrimps was evaluated.
PRP ¼ 1 % of morality ðtreatedÞ
% of mortality ðcontrolÞ
 
 100
Tissue level accumulation of active principles of D. nigra in shrimp tissue was detected
after 24 h of post-treatment. Randomly harvested shrimps were killed under ice and peeled
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extracted three times with methanol–dichloromethane (1:1). The extract was centrifuged
at 10000 rpm at 4 jC for 15 min. The combined extract was adjusted to pH 6.4 and diluted
with KH2PO4 buffer (pH 6.4) for microbial assay. Micrococcus luteus (ATCC 9341),
which showed maximum sensitivity in the in vitro antibacterial activity, was used as test
organism for the detection of residual antibacterial agents in shrimp tissue (Selvin and
Lipton, 2003a) using modified cylinder plate method (USP, 1995).3. Results and discussion
The survival rate was found to be significant ( p<0.01) in the Dendrilla treated group
(Table 1). The shrimps challenged with lethal dose and potentiated pathogen were
produced more infection or mortality in the treated group than those caused by the
MLD of individual pathogens. In the case of V. fischeri, the MLD did not cause
mortality in the treated group while all the control shrimps died. At 108 cfu/shrimp,
60% mortality and 40% infection in the Dendrilla fed group was noted. The infected
shrimps showed external signs such as shell necrosis and black spots on the shell,
necrotised chelate legs, anorexia and folded tail. Dendrilla feed elicited complete
protection (100% survival) against the most common shrimp pathogens such as
luminescent V. harveyi and V. alginolyticus.
Albeit Dendrilla gave 100% survival against Vibrio sp., the inoculation of lethal dose
(107 cfu/shrimp) of Aeromonas sp. caused 40% mortality and 20% infection in the treated
group. This might be due to the broad spectrum vibriostatic activity of Dendrilla (Selvin
and Lipton, 2004). Invariably, maximum PRP was obtained in the treated shrimps
challenged with MLD of appropriate pathogen. Dendrilla exhibited 75% survival in the
P. monodon challenged with potentiated pathogen. It is well known that the residual
accumulation of antibiotics in the shrimp tissue will pose severe environmental and public
health problems (Selvin and Lipton, 2003a). The active ingredients of Dendrilla were not
accumulated in the shrimp tissue after 24 h of post dosing. The mechanism of action ofTable 1
Efficacy of Dendrilla feed (500 mg/kg) and PRP of P. monodon towards shrimp pathogens
Bacterial Dose Cumulative mortality within 15 days (%) PRP Percentage infection
pathogens (cfu/shrimp)
Control (n=10) Treateda (n=20)
in the treated shrimp
(n=20)
V. fischeri 108 100 60 60 40
107 100 0 100 0
V. harveyi 106 100 0 100 0
V. alginolyticus 106 100 0 100 25
Aeromonas sp. 107 100 40 60 20
106 80 0 100 0
Potentiated pathogen 107 100 25 75 25
V. harveyi 5106
V. alginolyticus 5106
a Based on the cumulative mortality, the calculated survival rate was significant at p<0.01.
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Dendrilla diet did not influence the host defense system of shrimp (Selvin et al., 2004).
Therefore, the protection elicited by Dendrilla could be due to its antibiotic effect rather
than its influence on the host defense system. Therefore, Dendrilla medication may form a
suitable alternative to replace conventional antibiotics.
In the culture system, shrimps are constantly exposed to a myriad of bacterial pathogens
(Raa et al., 1992; Lightner, 1988). It may be difficult to ascribe mortality to any single
pathogen. It was reported that secondary infection among shrimp and red disease
syndrome arose due to multiple bacterial pathogens (Karunasagar et al., 1997; Tendencia
and Dureza, 1997). Results of combined bacterial challenge indicated that Dendrilla was a
broad spectrum vibriostatic agent. Literature evidenced that biological potency of D. nigra
is virtually an untapped resource. In vitro studies in our laboratory indicated that D. nigra
contained biologically active agents. It exhibited potent antibacterial, antifungal, brine
shrimp cytotoxicity, microalgal lethality, insecticidal, anticoagulant, anti-fouling and anti-
predation (ichthyotoxic) activities (Selvin and Lipton, 2004). The actual mechanism of
such broad spectrum of bioactivity exhibited by a single species was not known. As crude
extracts only were used, they may contain more than one compound or active principles.
Manzamine-type alkaloids isolated from the Philippine marine sponge Xestospongia
ashmorica showed insecticidal, antibacterial and cytotoxicity activities (Edrada et al.,
1996). Cacospongionolide, B a new sesterpene, isolated from Lascispongia covernosa
showed antimicrobial activity, brine shrimp cytotoxicity and ichythyotoxicity (de-Rosa et
al., 1995). The crude extracts of Caribbean sponges Ircinia campassa, Verongula rigida,
Agelas conifera and Discus oxeata were found to have ichthyotoxic, cytotoxic and
antimicrobial activities (Zea et al., 1986).
Findings of the present study indicated that bycatch collection of D. nigra forms a
reliable source for the development of shrimp therapeutants. However, no literature
available on the aspects of bycatch landing of sponges and their biological potential.
Therefore, it is inevitable to explore the chemical ecology of secondary metabolite
synthesis. A number of bacteria and cyanobacteria associated among sponges were found
to be the sources of antibiotics and other bioactive compounds in the marine environment.
It was reported that the wider biosynthetic capabilities of sponges were associated with the
symbiotic microorganism (Abrell, 1997). A purple-coloured bacterium isolated from the
Adocia sp. produced antibiotic O-aminophenol (Oclarit et al., 1994). The marine
bacterium, Pseudomonas isolated from its host sponge Suberea creba collected from the
coral sea of New Caledonia produced strong antibiotic quinones (Debitus et al., 1998).
One of the study on the chemical ecology of sponges in our laboratory indicated that the
antibacterial secondary metabolites of Dendrilla might have synthesized by the associated
bacterial species. Research is being underway on the aspects of chemical ecology of
sponge-associated endosymbionts and their potential in shrimp disease management.Acknowledgements
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